You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2025

Drugs Containing Excipient (Inactive Ingredient) GLYCERYL BEHENATE/EICOSADIOATE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing GLYCERYL BEHENATE/EICOSADIOATE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Glyceryl Behenate/Eicosadioate

Introduction

Glyceryl Behenate/Eicosadioate is a versatile pharmaceutical excipient that has garnered significant attention in the cosmetic and pharmaceutical industries. This ingredient, a mixture of esters of glycerin with behenic and eicosadioic acids, serves multiple functions, including thickening and gelling oils. Here, we delve into the market dynamics and financial trajectory of this excipient.

What is Glyceryl Behenate/Eicosadioate?

Glyceryl Behenate/Eicosadioate is a monoester of polyglycerin-10 and a blend of behenic and eicosadioic acids. It is widely used as a thickening agent to create a viscous gel texture in various formulations, particularly in oils, which can result in a thixotropic texture[1][3][5].

Market Growth Outlook

The pharmaceutical excipients market, which includes Glyceryl Behenate/Eicosadioate, is expected to grow significantly. The global pharmaceutical excipients market is forecasted to increase from USD 10.0 billion in 2023 to USD 13.9 billion by 2028, driven by a Compound Annual Growth Rate (CAGR) of 6.8%[4].

Drivers of Market Growth

Several factors are driving the growth of the pharmaceutical excipients market, including:

Increasing Demand for Generic Drugs

The rising demand for generic drugs, which are cheaper than branded drugs, is a significant driver. Generic drug manufacturers are looking for cost-effective excipients, and Glyceryl Behenate/Eicosadioate, with its affordability and effectiveness, is a preferred choice[4].

Increased R&D Investments

Investments in research and development to create novel excipients are on the rise. This includes the development of specialized excipients that cater to patient-centric formulations, which can further boost the demand for Glyceryl Behenate/Eicosadioate[4].

Growing Emphasis on Patient-Centric Formulations

There is an increasing focus on patient-centric formulations that require specialized excipients. Glyceryl Behenate/Eicosadioate, with its ability to create specific textures, is well-positioned to benefit from this trend[4].

Collaborations and Partnerships

Collaborations between pharmaceutical companies and excipient manufacturers for customized solutions are becoming more common. This can lead to increased demand for high-quality excipients like Glyceryl Behenate/Eicosadioate[4].

Financial Trajectory

The financial trajectory of Glyceryl Behenate/Eicosadioate is closely tied to the overall pharmaceutical excipients market.

Revenue Potential

Given the projected growth of the pharmaceutical excipients market, the revenue potential for Glyceryl Behenate/Eicosadioate is significant. As the market expands, the demand for this excipient is likely to increase, driving up sales and revenue.

Cost and Pricing Analysis

The cost of Glyceryl Behenate/Eicosadioate can vary based on the supplier and the specific formulation requirements. However, it is generally considered a cost-effective option, which is a key factor in its adoption by generic drug manufacturers. The pricing analysis indicates that the cost of this excipient is competitive, making it an attractive choice for pharmaceutical companies looking to reduce costs[4].

Challenges and Restraints

While the market for Glyceryl Behenate/Eicosadioate is growing, there are several challenges and restraints to consider:

Stringent Regulatory Requirements

Pharmaceutical excipients, including Glyceryl Behenate/Eicosadioate, are subject to stringent regulatory requirements. Ensuring compliance with these regulations can be costly and time-consuming[4].

High Development Costs

The development of new excipients and the improvement of existing ones involve high costs. This can be a barrier to entry for new manufacturers and a challenge for existing ones[4].

Safety and Quality Concerns

Ensuring the safety and quality of excipients is crucial. Any safety or quality issues can impact the market negatively and affect the financial trajectory of Glyceryl Behenate/Eicosadioate[4].

Applications and Usage

Glyceryl Behenate/Eicosadioate is used in a variety of applications:

Cosmetic Industry

In the cosmetic industry, it is used to create viscous gel textures in products such as face and body concealers, UV fluids, and lip care products. Examples include NYX Professional Makeup Bare With Me Hydrating Face & Body Concealer Serum and Estee Lauder Multi-Defense UV Fluid SPF 45 with 8 Anti-Oxidants[3].

Pharmaceutical Industry

In pharmaceuticals, it serves as a thickening agent and gelling agent for oils in various formulations. Its ability to create thixotropic textures makes it particularly useful in patient-centric formulations[3].

Product Characteristics and Usage Guidelines

  • Appearance: White or pale yellow waxy solid or powder[3].
  • Solubility: Can be dissolved in oil with a temperature of 65°C[3].
  • Utilization Rate: Typically used at a rate of 0.1-10% (higher consumption may make the formula thicker)[3].
  • Storage: Can be stored at room temperature, away from sunlight and heat[3].

Safety and Regulatory Status

Glyceryl Behenate/Eicosadioate is not currently on the Environmental Working Group's (EWG) Skin Deep Restricted or Unacceptable Lists. It has low concerns for irritation, cancer, allergies, and developmental and reproductive toxicity[1][5].

Key Takeaways

  • Glyceryl Behenate/Eicosadioate is a versatile excipient used in both cosmetic and pharmaceutical industries.
  • The market for this excipient is driven by increasing demand for generic drugs, R&D investments, and a focus on patient-centric formulations.
  • Despite growth, the market faces challenges such as stringent regulatory requirements and high development costs.
  • The excipient is safe for use and has low concerns for various health and environmental issues.

FAQs

Q: What is Glyceryl Behenate/Eicosadioate used for?

A: Glyceryl Behenate/Eicosadioate is used as a thickening agent to create a viscous gel texture in oils, particularly in cosmetic and pharmaceutical formulations.

Q: Is Glyceryl Behenate/Eicosadioate safe for use?

A: Yes, it is considered safe with low concerns for irritation, cancer, allergies, and developmental and reproductive toxicity[1][5].

Q: How is Glyceryl Behenate/Eicosadioate typically used in formulations?

A: It is mixed into oils by heating to 65°C until melted and is used at a rate of 0.1-10%[3].

Q: What are the market drivers for Glyceryl Behenate/Eicosadioate?

A: The market is driven by the increasing demand for generic drugs, R&D investments, and a growing emphasis on patient-centric formulations[4].

Q: Are there any regulatory challenges for Glyceryl Behenate/Eicosadioate?

A: Yes, the market faces challenges such as stringent regulatory requirements and high development costs[4].

Sources

  1. EWG Skin Deep® | What is POLYGLYCERYL 10 BEHENATE
  2. Amended Safety Assessment of Monoglyceryl Monoesters as Used ...
  3. Glyceryl Behenate/Eicosadioate - MySkinRecipes
  4. Pharmaceutical Excipients Market Growth, Drivers, and Opportunities
  5. EWG Skin Deep® | What is GLYCERYL BEHENATE/EICOSADIOATE

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.